Hydrogen Peroxide Activates Mitogen-activated Protein Kinases and Na+-H+ Exchange in Neonatal Rat Cardiac Myocytes
Overview
Authors
Affiliations
Reperfusion of cardiac tissue after an ischemic episode is associated with metabolic and contractile dysfunction, including reduced tension development and activation of the Na+-H+ exchanger (NHE). Oxygen-derived free radicals are key mediators of reperfusion abnormalities, although the cellular mechanisms involved have not been fully defined. In the present study, the effects of free radicals on mitogen-activated protein (MAP) kinase function were investigated using cultured neonatal rat ventricular myocytes. Acute exposure of spontaneously beating myocytes to 50 micromol/L hydrogen peroxide (H2O2) caused a sustained decrease in contraction amplitude (80% of control). MAP kinase activity was measured by in-gel kinase assays and Western blot analysis. Acute exposure to H2O2 (100 micromol/L, 5 minutes) resulted in sustained MAP kinase activation that persisted for 60 minutes. Catalase, but not superoxide dismutase, completely inhibited MAP kinase activation by H2O2. Pretreatment with chelerythrine (10 micromol/L, 45 minutes), a protein kinase C inhibitor, or genistein (75 micromol/L, 45 minutes) or herbimycin A (3 micromol/L, 45 minutes), tyrosine kinase inhibitors, caused significant inhibition of H2O2-stimulated MAP kinase activity (51%, 78%, and 45%, respectively, at 20 minutes). Brief exposure to H2O2 also stimulated NHE activity. This effect was completely abolished by pretreatment with the MAP kinase kinase inhibitor PD 98059 (30 micromol/L, 60 minutes). These results suggest that low doses of H2O2 induce MAP kinase-dependent pathways that regulate NHE activity during reperfusion injury.
Cardioprotection and neurobehavioral impact of swimming training in ovariectomized rats.
Ibanez A, Coto J, Martinez V, Del Milagro Yeves A, Dolcetti F, Cervellini S Geroscience. 2024; .
PMID: 39527177 DOI: 10.1007/s11357-024-01422-7.
Karmazyn M, Pierce G, Fliegel L Rev Cardiovasc Med. 2024; 23(8):284.
PMID: 39076631 PMC: 11266974. DOI: 10.31083/j.rcm2308284.
Dual targeting of KDM1A and antioxidants is an effective anticancer strategy.
Mudambi S, Fitzgerald M, Washington D, Pera P, Huss W, Paragh G bioRxiv. 2024; .
PMID: 38915482 PMC: 11195178. DOI: 10.1101/2024.06.12.597953.
Empagliflozin improves cardiac function in rats with chronic heart failure.
Wang Z, Liu Q, Wang X, Wang P, Wang Z, Zhang F Naunyn Schmiedebergs Arch Pharmacol. 2023; 397(2):1037-1044.
PMID: 37566305 DOI: 10.1007/s00210-023-02655-7.
Werbner B, Tavakoli-Rouzbehani O, Fatahian A, Boudina S J Cardiovasc Aging. 2023; 3(1).
PMID: 36742465 PMC: 9894375. DOI: 10.20517/jca.2022.42.